Obinutuzumab

GAZYVARO 1000 mg CONCENTRADO PARA SOLUCION PARA PERFUSION

1000 mg concentrado para solución para perfusiónSpainMarketedAuthorised 8 Jan 2021

In other countries

The same active substances on other registers, the same brand first.

GazyvaroEuropean Union · Roche Registration GmbHSame brand
GazyvaroCroatiaSame brand
GazyvaroItaly · Concentrato per soluzione per infusione · Roche Registration GMBHSame brand
Gazyvaro 1000 mg, concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Roche Registration GmbHSame brand
GAZYVARO 1000 mgRomania · 1000mg · conc. pt. sol. perf. · Roche Registration GMBHSame brand
GAZYVARO 1000mgRomania · 1000mg · conc. pt. sol. perf. · Roche Registration LTDSame brand
BaxterNew Zealand · Inj 1 mg for ECPSame form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Obinutuzumab

GAZYVARO 1000 mg CONCENTRADO PARA SOLUCION PARA PERFUSION

1000 mg concentrado para solución para perfusiónSpainMarketedAuthorised 8 Jan 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

GazyvaNew Zealand · Inj 25 mg per ml, 40 ml vial

GAZYVA 25 mg/ml concentrate for solution for infusionSaudi Arabia · Roche Diagnostics

Gazyva Concentrate for Solution for Infusion 1000MG/40MLSingapore · 1000 mg/40 mL · infusion, solution concentrate · Roche Singapore Pte. LTD.

GazyvaUnited States · 1000MG/40ML · injectable · Genentech

GazyvaBrazil · Produtos Roche Químicos e Farmacêuticos S.A.

GazyvaCanada · 25 MG / ML · Solution · Hoffmann-LA Roche Limited

Gazyva®Serbia · 1000mg · koncentrat za rastvor za infuziju · Roche DOO Beograd

Packs

Pack	Code	Status
GAZYVARO 1000 mg CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 40 ml	730079

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Obinutuzumab
Strength: 1000 mg
Dosage form: concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 8 Jan 2021
Registration: 114937001IP
Marketing authorisation holder: Roche Registration Gmbh
Procedure: EU centralised
Supply: Uso Hospitalario